<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Eleven patients with malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were treated with total body irradiation </plain></SENT>
<SENT sid="1" pm="."><plain>This therapy was performed during 3 weeks with a midline dose of 70 to 100 rd </plain></SENT>
<SENT sid="2" pm="."><plain>Two patients were treated two times after an internal of 3 months </plain></SENT>
<SENT sid="3" pm="."><plain>The authors studied the hematologic side effects of this therapy </plain></SENT>
<SENT sid="4" pm="."><plain>The irradiation caused a diminution of leucocytes of 73% of the initial value (range 16,7 to 98,4%), the neutrophilic granulocytes were reduced by 60% (24-95%), the thrombocytes were reduced by 57% (12-73%) </plain></SENT>
<SENT sid="5" pm="."><plain>The lowest values were seen during the fourth and sixth week of observation or one to three weeks after the end of therapy </plain></SENT>
<SENT sid="6" pm="."><plain>In patients with <z:hpo ids='HP_0001908'>hypoplastic anemia</z:hpo> the number of reticulocytes was reduced to zero with a further fall of hematocrit and replacement therapy was necessary </plain></SENT>
<SENT sid="7" pm="."><plain>The pool of circulating CFUc was reduced to zero in nine of twelve observations up to six weeks after therapy </plain></SENT>
</text></document>